EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, DVAX: Dynavax Technologies

10 Dec 25 17:42
LAST:

10.90

CHANGE:
 0.01		OPEN:
10.91		HIGH:
10.96		ASK:
22.45		VOLUME:
1.21M
CHG(%):
0.09		PREV:
10.89		LOW:
10.71		BID:
20.85		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Dec 2510.9110.9610.7110.901.21M
09 Dec 2510.9711.1110.8610.891.71M
08 Dec 2510.9711.1810.8710.972.02M
05 Dec 2510.9511.0310.8710.891.08M
04 Dec 2510.9611.0310.7910.961.5M
03 Dec 2510.8811.1010.8610.971.52M
02 Dec 2510.7010.9210.6610.881.71M
01 Dec 2511.2311.3110.6310.712.35M
28 Nov 2511.4411.4911.3411.37836.3K
26 Nov 2511.4311.5311.3311.431.58M

PROFILE

Name:Dynavax Technologies
About:Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccine candidate in Phase 1/2 clinical trial for the prevention of shingles in adults aged 50 years and older, as well as HEPLISAV-B for adults on hemodialysis. The company sells its products to hospitals and clinics, integrated delivery networks, public health clinics and prisons, the Department of Defense, the Department of Veterans Affairs, and retail pharmacies through wholesalers and specialty distributors. It has a collaboration agreement with the U.S. Department of Defense; Coalition for Epidemic Preparedness Innovations; Zhejiang Clover Biopharmaceuticals, Inc.; Clover Biopharmaceuticals (Hong Kong) Co., Limited; and Biological E. Limited. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
Sector:Healthcare
Address:2100 Powell Street, EmeryVille, CA, United States, 94608
Website:https://www.dynavax.com
CUSIP:268158102
CIK:0001029142
ISIN:US2681582019
FIGI:BBG000BFX694
LEI:549300T5URIXWDILX594

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:54.60 
Forward P/E:28.50 
PEG Ratio:0.70 
Price to Sales:3.80 
Price to Book:2.43 
Profit Margin:-0.17 
Operating Margin:0.17 
Return on Assets:0.01 
Return on Equity:-0.09 
EPS Ratio:-0.45 
Revenue:316.27M 
EBITDA:45.7M 
Shares:117.27M 
Market Cap:1.278B 

TECHNICAL INDICATORS

MA5:10.920.2%
MA10:11.000.9%
MA20:11.091.7%
MA50:10.602.9%
MA100:10.484.0%
MA200:10.870.3%
STO9:24.36
STO14:21.84
RSI14:46.58
WPR14:-75.00
MTM14:0.10
ROC14:0.01 
ATR:0.32 
Week High:11.182.6%
Week Low:10.711.8%
Month High:11.586.2%
Month Low:10.630.3%
Year High:14.6334.2%
Year Low:9.2018.5%
Volatility:3.47 

RECENT SPLITS

Date Ratio
10 Nov 20141-10